[Chemotherapy of infections in the Third World].
D000562:Amebiasis / Q000188:drug therapy; D000818:Animals; D000966:Antimony Potassium Tartrate / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003906:Developing Countries; D003968:Diarrhea, Infantile / Q000401:mortality; D004353:Drug Evaluation, Preclinical; D004467:Economics; D005511:Food Handling; D014943:Global Health; D006801:Humans; D007231:Infant, Newborn; D007896:Leishmaniasis / Q000188:drug therapy; D008288:Malaria / Q000401:mortality / Q000628:therapy; D008463:Mebendazole / Q000627:therapeutic use; D009349:Nematode Infections / Q000188:drug therapy; D010272:Parasitic Diseases / Q000188:drug therapy*; D010419:Pentamidine / Q000627:therapeutic use; D010571:Pest Control; D010963:Plasmodium falciparum; D010966:Plasmodium vivax; D011203:Poverty; D011528:Protozoan Infections / Q000188:drug therapy; D051381:Rats; D012552:Schistosomiasis / Q000628:therapy; D013752:Tetracycline / Q000627:therapeutic use; D014318:Tritrichomonas; D014344:Trypanocidal Agents / Q000627:therapeutic use
D014344:Trypanocidal Agents; D010419:Pentamidine; D008463:Mebendazole; D003520:Cyclophosphamide; D000966:Antimony Potassium Tartrate; D013752:Tetracycline
Chemioterapia delle infezioni del terzo mondo.